A Review and Analysis of Key Biomarkers in Alzheimer's Disease

Overview

Journal Front Neurosci

Date 2024 Mar 6

PMID 38445255

Authors

Zhihao Zhang

Xiangtao Liu

Suixia Zhang

Zhixin Song

Ke Lu

Wenzhong Yang

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects over 50 million elderly individuals worldwide. Although the pathogenesis of AD is not fully understood, based on current research, researchers are able to identify potential biomarker genes and proteins that may serve as effective targets against AD. This article aims to present a comprehensive overview of recent advances in AD biomarker identification, with highlights on the use of various algorithms, the exploration of relevant biological processes, and the investigation of shared biomarkers with co-occurring diseases. Additionally, this article includes a statistical analysis of key genes reported in the research literature, and identifies the intersection with AD-related gene sets from databases such as AlzGen, GeneCard, and DisGeNet. For these gene sets, besides enrichment analysis, protein-protein interaction (PPI) networks utilized to identify central genes among the overlapping genes. Enrichment analysis, protein interaction network analysis, and tissue-specific connectedness analysis based on GTEx database performed on multiple groups of overlapping genes. Our work has laid the foundation for a better understanding of the molecular mechanisms of AD and more accurate identification of key AD markers.

Citing Articles

Biomarker Identification for Alzheimer's Disease Using a Multi-Filter Gene Selection Approach.

Pashaei E, Pashaei E, Aydin N Int J Mol Sci. 2025; 26(5).

PMID: 40076442 PMC: 11898513. DOI: 10.3390/ijms26051816.

Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer's disease.

Branciamore S, Gogoshin G, Rodin A, Myers A Sci Rep. 2024; 14(1):14954.

PMID: 38942763 PMC: 11213882. DOI: 10.1038/s41598-024-65010-7.

References

Kolsch H, Lehmann D, Ibrahim-Verbaas C, Combarros O, Van Duijn C, Hammond N . Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project. J Neural Transm (Vienna). 2011; 119(4):473-9. DOI: 10.1007/s00702-011-0732-4. View

Qin H, Hu C, Zhao X, Tian M, Zhu B . Usefulness of candidate mRNAs and miRNAs as biomarkers for mild cognitive impairment and Alzheimer's disease. Int J Neurosci. 2021; 133(1):89-102. DOI: 10.1080/00207454.2021.1886098. View

Lin L, Basu R, Chatterjee D, Templin A, Flak J, Johnson T . Disease-associated astrocytes and microglia markers are upregulated in mice fed high fat diet. Sci Rep. 2023; 13(1):12919. PMC: 10412627. DOI: 10.1038/s41598-023-39890-0. View

Ye X, Liu M, Wang X, Cheng S, Li C, Bai Y . Exploring the common pathogenesis of Alzheimer's disease and type 2 diabetes mellitus microarray data analysis. Front Aging Neurosci. 2023; 15:1071391. PMC: 10008874. DOI: 10.3389/fnagi.2023.1071391. View

Shigemizu D, Akiyama S, Higaki S, Sugimoto T, Sakurai T, Boroevich K . Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data. Alzheimers Res Ther. 2020; 12(1):145. PMC: 7656734. DOI: 10.1186/s13195-020-00716-0. View

Li T, Qu J, Xu C, Fang T, Sun B, Chen L . Exploring the common gene signatures and pathogeneses of obesity with Alzheimer's disease transcriptome data. Front Endocrinol (Lausanne). 2022; 13:1072955. PMC: 9780446. DOI: 10.3389/fendo.2022.1072955. View

Abyadeh M, Tofigh N, Hosseinian S, Hasan M, Amirkhani A, Fitzhenry M . Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer's Disease. Cells. 2022; 11(6). PMC: 8946735. DOI: 10.3390/cells11060987. View

Li W, Li G, Tong X, Yang P, Huang J, Xu L . Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases. Aging (Albany NY). 2020; 12(10):9882-9914. PMC: 7288927. DOI: 10.18632/aging.103253. View

Wang X, Liu S, Lu H, Guan Y, Wu H, Ji Y . Analysis of Shared Genetic Regulatory Networks for Alzheimer's Disease and Epilepsy. Biomed Res Int. 2021; 2021:6692974. PMC: 8538392. DOI: 10.1155/2021/6692974. View

10.

Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B . Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52. PMC: 4767558. DOI: 10.1038/ng.3506. View

11.

Sun X, Zhang H, Yao D, Xu Y, Jing Q, Cao S . Integrated Bioinformatics Analysis Identifies Hub Genes Associated with Viral Infection and Alzheimer's Disease. J Alzheimers Dis. 2021; 85(3):1053-1061. DOI: 10.3233/JAD-215232. View

12.

Chen S, Chang Y, Li L, Acosta D, Li Y, Guo Q . Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer's disease. Acta Neuropathol Commun. 2022; 10(1):188. PMC: 9773466. DOI: 10.1186/s40478-022-01494-6. View

13.

Yang F, Diao X, Wang F, Wang Q, Sun J, Zhou Y . Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer's Disease. Interdiscip Sci. 2020; 12(1):90-98. DOI: 10.1007/s12539-019-00353-8. View

14.

Castora F, Kerns K, Pflanzer H, Hitefield N, Gershon B, Shugoll J . Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients. J Alzheimers Dis. 2022; 90(1):119-137. DOI: 10.3233/JAD-220161. View

15.

Jin Y, Ren Z, Wang W, Zhang Y, Zhou L, Yao X . Classification of Alzheimer's disease using robust TabNet neural networks on genetic data. Math Biosci Eng. 2023; 20(5):8358-8374. DOI: 10.3934/mbe.2023366. View

16.

Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodriguez I, Cadena-Suarez A, Sanchez-Garibay C . Alzheimer's Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023; 24(4). PMC: 9966419. DOI: 10.3390/ijms24043754. View

17.

Soheili-Nezhad S, van der Linden R, Rikkert M, Sprooten E, Poelmans G . Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology. Alzheimers Dement. 2020; 17(3):489-499. PMC: 8048495. DOI: 10.1002/alz.12211. View

18.

Sekaran K, Alsamman A, George Priya Doss C, Zayed H . Bioinformatics investigation on blood-based gene expressions of Alzheimer's disease revealed ORAI2 gene biomarker susceptibility: An explainable artificial intelligence-based approach. Metab Brain Dis. 2023; 38(4):1297-1310. PMC: 9942063. DOI: 10.1007/s11011-023-01171-0. View

19.

Rahman M, Islam T, Shahjaman M, Zaman T, Faruquee H, Hena Mostofa Jamal M . Discovering Biomarkers and Pathways Shared by Alzheimer's Disease and Ischemic Stroke to Identify Novel Therapeutic Targets. Medicina (Kaunas). 2019; 55(5). PMC: 6572146. DOI: 10.3390/medicina55050191. View

20.

Liang J, Fang Z, Huang Y, Liuyang Z, Zhang X, Wang J . Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease. J Alzheimers Dis. 2018; 65(4):1353-1364. PMC: 6218130. DOI: 10.3233/JAD-180400. View